Skip to main content
  • Author Correction
  • Open access
  • Published:

Correction: Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist

The Original Article was published on 22 October 2021

Correction to: Genome Biol 22, 297 (2021).

Following publication of the original article [1], the authors identified an error in the author affiliations presented in additional file 1. The additional file has been updated and published in this correction.

The original article [1] has been corrected.


  1. Mei H, Zha Z, Wang W, Xie Y, Huang Y, Li W, et al. Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist. Genome Biol. 2021;22(1):297.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Jieming Qu or Jia Liu.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Fig. S1.

Construction of CRISPR genome-wide and surfaceome libraries. Fig. S2. Quality analyses of constructed genome-wide and surfaceome CRISPR libraries. Fig. S3. Evaluation of surfaceome and genome-wide CRISPR libraries. Fig. S4. Validation of the screening results. Fig. S5. Determination of gene modification efficiency. Fig. S6. Validation of the top 10 hits from surfaceome and genome-wide screens. Fig. S7. Construction and validation of single clones of ICAM-1−/−, RAB5C−/−, OLFML3−/−, SLC4A7−/− and ATP6AP1−/+ H1-Hela cells. Fig. S8. Validation of the effects of ICAM-1, RAB5C and OLFML3 on RV infection, related to Fig. 3. Fig. S9. Dissection of the functions of RAB5C and OLFML3 in RV infection. Fig. S10. RNA-seq analyses of the effects of RAB5C knockout on RV infection. Fig. S11. RNA-Seq analyses of the effects of OLFML3 on RV infection (related to Fig. 4). Fig. S12. Bar plots showing RT-qPCR quantification of ISG expression in mock and OLML3−/− cells at 24 h post infection of RV-B14 (a) and RV-A16 (b) at an MOI of 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mei, H., Zha, Z., Wang, W. et al. Correction: Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist. Genome Biol 22, 314 (2021).

Download citation

  • Published:

  • DOI: